CancerIQ
Signal active
Organization
Contact Information
Overview
CancerIQ provides a precision prevention platform that empowers healthcare providers to engage patients, stratify risk and ensure adherence with the latest evidence-based strategies to get ahead of cancer. It offers a robust content library of evidence-based guidelines and risk models to help providers interpret data and navigate patients to the appropriate genetic testing, screening, or treatment interventions.
About
Industries
Information Technology, Health Care, Medical
Founded
2013
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
CancerIQ headquartered in United States, North America, operates in the Information Technology, Health Care, Medical sector. The company focuses on Information Technology and has secured $1.7B in funding across 84 round(s). With a team of 11-50 employees, CancerIQ is actively contributing to advancements in Information Technology. Their latest funding round, Seed Round - CancerIQ, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$20.0M
Details
4
CancerIQ has raised a total of $20.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2014 | Seed | |||
| 2020 | Early Stage Venture | 4.8M | ||
| 2022 | Early Stage Venture | 14.0M | ||
| 2013 | Seed |
Investors
CancerIQ is funded by 24 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cleveland Avenue | - | FUNDING ROUND - Cleveland Avenue | undefined |
| Donna Harris | - | FUNDING ROUND - Donna Harris | 1.2M |
| CancerIQ | - | FUNDING ROUND - CancerIQ | 1.2M |
| 1776 Ventures | - | FUNDING ROUND - 1776 Ventures | 1.2M |
Recent Activity
There is no recent news or activity for this profile.